The fragile X mental retardation protein (FMRP) plays an important role in normal brain development. Absence of FMRP results in abnormal neuronal morphologies in a selected manner throughout the brain, leading to intellectual deficits and sensory dysfunction in the fragile X syndrome (FXS). Despite FMRP importance for proper brain function, its overall expression pattern in the mammalian brain at the resolution of individual neuronal cell groups is not known. In this study we used FMR1 knockout and isogenic wildtype mice to systematically map the distribution of FMRP expression in the entire mouse brain. Using immunocytochemistry and cellular quantification analyses, we identified a large number of prominent cell groups expressing high levels of FMRP at the subcortical levels, in particular sensory and motor neurons in the brainstem and thalamus. In contrast, many cell groups in the midbrain and hypothalamus exhibit low FMRP levels. More important, we describe differential patterns of FMRP distribution in both cortical and subcortical brain regions. Almost all major brain areas contain high and low levels of FMRP cell groups adjacent to each other or between layers of the same cortical areas. These differential patterns indicate that FMRP expression appears to be specific to individual neuronal cell groups instead of being associated with all neurons in distinct brain regions, as previously considered. Taken together, these findings support the notion of FMRP differential neuronal regulation and strongly implicate the contribution of fundamental sensory and motor processing at subcortical levels to FXS pathology. J. Comp. Neurol. 525:818-849, 2017. 
brainstem and thalamus. In contrast, many cell groups in the midbrain and hypothalamus exhibit low FMRP levels. More important, we describe differential patterns of FMRP distribution in both cortical and subcortical brain regions. Almost all major brain areas contain high and low levels of FMRP cell groups adjacent to each other or between layers of the same cortical areas. These differential patterns indicate that FMRP expression appears to be specific to individual neuronal cell groups instead of being associated with all neurons in distinct brain regions, as previously considered. Taken together, these findings support the notion of FMRP differential neuronal regulation and strongly implicate the contribution of fundamental sensory and motor processing at subcortical levels to FXS pathology. J. Comp. Neurol. 525:818-849, 2017 . INDEXING TERMS: fragile X syndrome; whole brain analyses; cortical laminar heterogeneity; subcortical sensory systems; sensory information processing; RRID:AB_10805421; RRID:AB_1157880; RRID:AB_476743 Loss of the fragile X mental retardation protein (FMRP) leads to fragile X syndrome (FXS) in children, the leading known genetic cause of autism spectrum disorders (Verkerk et al., 1991; Penagarikano et al., 2007; Bagni et al., 2012; Santoro et al., 2012) . FMRP is encoded by the X-linked gene FMR1. Transcriptional silencing of FMR1 leads to loss of FMRP protein and abnormal neuronal structure and function (Rudelli et al., 1985; Hinton et al., 1991; Braun and Segal, 2000; Irwin et al., 2001 Irwin et al., , 2002 Galvez et al., 2003 Galvez et al., , 2005 McKinney et al., 2005; Levenga et al., 2011; Till et al., 2012) . Phenotypically, patients exhibit intellectual disability including learning and memory deficits, communication and social difficulties, as well as sensory and motor dysfunction. Consistent with these observations, FMRP is highly expressed in healthy brains, particularly in neuronal structures (Devys et al., 1993; Hinds et al., 1993; Gholizadeh et al., 2015) .
To explore FMRP mechanisms in normal brain development and function, as well as the contribution of FMRP loss to FXS phenotypes, it is important to understand the expression patterns of FMRP in the brain. Earlier studies reported intensive FMRP expression in the hippocampus, cerebellum, nucleus basalis, cerebral cortex, and olfactory bulb, while reporting minimal or generally low levels of FMRP in other brain areas such as corpus callosum, brainstem, and thalamus (Hinds et al., 1993; Devys et al., 1993; Abitbol et al., 1993; Bakker et al., 2000; Zangenehpour et al., 2009 ). More recent studies, however, demonstrated that FMRP is distributed throughout the brain and is expressed in most, if not all, neurons (Feng et al., 1997; Christie et al., 2009) . In certain cases, the expression level of FMRP appears highly heterogeneous. Hinds et al. (1993) reported a "dense yet patchy" labeling pattern of FMR1 hybridization in the mouse cortex. In the visual thalamus, a high FMRP expression level is detected in the magnocellular, but not parvocellular, neurons of the primate lateral geniculate nucleus (Kogan et (Kogan et al., 2004a,b) . In the brainstem, our recent studies have identified high levels of FMRP in auditory neurons as compared to other neuronal cell types in adjacent areas Wang et al., 2014) , which is consistent with other reports in FMR1 knockout mice showing reduced cell size, altered synaptic connectivity, and reduced dynamics in ion channel regulation of auditory brainstem neurons (Strumbos et al., 2010; Rotschafer et al., 2015) . In addition, reduced FMR1 expression leads to structural abnormalities of dendritic spines in the hippocampus CA1, but not CA3 (Levenga et al., 2011) . These studies emphasize the importance of identifying FMRP-rich neuronal cell types in normal brains, as they could potentially be the prominent targets of FMRP loss and thus reasonable candidates for exploring FXS pathology.
Although systematic maps of a specialized presynaptic format of FMRP has been previously reported (Christie et al., 2009; Akins et al., 2012) , the overall FMRP distribution in the entire mammalian brain at the resolution of individual neuronal cell groups is not known. Using immunocytochemistry, the current study provides a detailed analysis of FMRP distribution in the whole brain of FVB mice, as the FMR1 knockout strain on this genetic background is commonly used for studying FMRP loss-induced neuronal deficits and for testing drug candidates for rescuing FXS phenotypes (for example, Bakker et al., 1994; Fisch et al., 1999; Chen and Toth, 2001; Irwin et al., 2002; Strumbos et al., 2010; La Fata et al., 2014) . When compared to their isogenic wildtype mice, FMR1 knockout mice on FVB background exhibit volume changes in more brain regions than FMR1 knockout mice on C57BL/6 background (Lai et al., 2016) and they show more dramatic behavioral alterations (Pietropaolo et al., 2011) .
The data presented in this study identify a number of distinct neuronal cell types that are particularly rich in FMRP at the subcortical levels, as well as differential patterns of FMRP distribution in both the cortical and subcortical brain regions.
MATERIALS AND METHODS Animals
FMR1 knockout (Hemi FVB.129P2-Pde6b1; #004624) mice and their wildtype littermates (FVB.129P2-Pde6b1; #004828) were purchased from the Jackson Laboratory (Bar Harbor, ME). Six wildtype and four knockout animals of 5-6 weeks old were used in this study. All procedures were approved by the Florida State University Institutional Animal Care and Use Committee and conformed to National Institutes of Health (NIH) guidelines.
Immunocytochemistry
The animals were anesthetized with a mixture of 100 mg/kg ketamine and 15 mg/kg xylazine and transcardially perfused with 0.9% saline followed by 4% paraformaldehyde in 0.1 M phosphate buffer (PB). The brains were removed from the skull and postfixed overnight in the same fixative. The brains were then transferred to 30% sucrose in PB until they sank, frozen on the stage of a sliding microtome, and then sectioned either coronally (three wildtype and two knockout) or parasagittally (three wildtype and two knockout) at 30 lm. Sections were collected in 0.01 M phosphatebuffered saline (PBS) into four alternate sets of serial sections and stained for Nissl substance or immunocytochemistry.
For FMRP immunostaining, the sections were mounted on gelatin-coated slides and dried at 378C overnight. Sections were then washed in PBS for 15 minutes, pretreated with 0.1% sodium borohydride in PBS for 10 minutes, washed in PBS for 15 minutes, incubated in heated 10 mM citrate buffer (pH 6.0) for 20 minutes in a water steamer, washed in PBS for 10 minutes, followed by 50 mM ammonium chloride in PBS for 15 minutes, then finally washed in PBS for 10 minutes. Sections were then incubated with primary antibody solutions diluted 1:500 in PBS with 0.3% Triton X-100 overnight at 48C, followed by biotinylated goat anti-IgG antibodies (1:200; Vector Laboratories, Burlingame, CA) for 1 hour at room temperature. Sections were incubated in avidin-biotin-peroxidase complex solution (ABC Elite kit; Vector Laboratories) diluted 1:100 in PBS with 0.3% Triton X-100 for 1 hour at room temperature. For visualization, sections were incubated for 3-7 minutes in 0.015% 3-3 0 -diaminobenzidine (Sigma, St. Louis, MO), either with 0.01% hydrogen peroxide in PB or with 0.03% hydrogen peroxide, 125 mM sodium acetate, 10 mM imidazole, and 100 mM nickel ammonium sulfate. Sections were then dehydrated, cleared, and coverslipped with DPX mounting medium (EMS, Hatfield, PA).
Antibody characterization
A number of monoclonal and polyclonal antibodies have been produced to detect FMRP. All of these antibodies detect FMRP bands on Western blot. However, many of them are not specific, as evidenced by extra bands on Western blot in addition to FMRP. While these antibodies provide a useful tool for Western blot and immunoprecipitation studies which separate FMRP from other proteins of different molecular weights or structure, they are less useful for studying cellular and subcellular protein localization in intact tissue samples using immunocytochemistry. Out of 13 commercially available anti-FMRP antibodies tested in our lab, we chose two antibodies, 7G1 and 2F5, to use for immunocytochemistry, as they show the most specific detection of the mouse FMRP in both Western blot and immunocytochemistry.
Monoclonal anti-FMRP antibody 7G1 was first generated by Brown et al. (2001) by immunizing FMR1 knockout mice with hexahistidine-tagged FMRP. The FMRP-epitope recognized by 7G1 is amino acid 354-368 of the mouse FMRP, in a region with no homology to the fragile X-related paralogs. The specificity of the antibody was characterized by Western blot in Brown et al. (2001) and further tested by both Western blot and immunocytochemistry in the current study (see Results).
Monoclonal anti-FMRP antibody 2F5 was produced by Gabel et al. (2004) by immunizing FMR1 knockout mice with an N-terminal fragment of human FMRP (residues 1-204). Immunocytochemical and Western blot analyses of wildtype and FMR1 knockout mice demonstrate that 2F5 is specific for FMRP, as first characterized in Gabel et al. (2004) and confirmed in the current study (see Results). The 2F5 antibody used in the current study was initially provided generously by Dr. Jennifer Darnel at the Rockefeller University and then purchased from the Developmental Studies Hybridoma Bank (DSHB, Iowa City, IA).
It is worthy to note that neither 7G1 nor 2F5 reveals substantial dendritic staining by light microscopy, except of the most proximal part of dendrites in some, but not all, neurons. Our previous study with a polyclonal antibody ab17722 (Abcam; San Francisco, CA) reveals prominent FMRP clusters throughout dendritic branches in the brainstem . Unfortunately, subsequent batches of the antibody lost specificity when compared to the first batch that we used, exhibiting non-FMRP staining throughout the FMR1 knockout mouse brain. Due to limited visualization of dendritic staining, the current study focuses on the description of somatic FMRP staining.
Mouse monoclonal anti-b-actin was used as a loading control in Western blot analysis. This antibody recognizes an epitope located on the N-terminal end of the b-isoform of actin. It specifically labels b-actin in a wide variety of tissues and species, as tested by Western blot (manufacturer's data sheet) and on mouse brains in the current study.
The optimal antibody concentration was obtained by running a series of concentration tests to avoid floor or ceiling truncation, including a negative control by omitting primary antibody. Immunogen, host species, clone type, manufacturer's information, as well as dilution used for each antibody in each species, are listed in Table 1 .
Western blot
Protein samples were harvested from flash-frozen brain tissue from wildtype and FMR1 knockout mice. Samples were homogenized in EDTA buffer (62.5 mM Tris-HCl pH 6.8, 2% sodium dodecyl sulfate [SDS] , 10% glycerol, 5% b-ME, 10 mM EDTA) using the Ultra-Turrax T10 homogenizer (IKA Works, Wilmington, NC). For each sample, 50 lg of protein in SDS buffer (2% SDS, 50 mM Tris pH 7.6, 5% glycerol and 0.025% bromophenol blue) was incubated at 708C for 10 minutes, resolved in NuPAGE 4-12% Bis-Tris Gels (Life Technologies, Carlsbad, CA), and then transferred onto PDVF membranes (GE Healthcare, Chicago, IL). After blocking in 5% milk in PBS with 0.05% Tween (PBS-T) for 30 minutes at room temperature, membranes were probed against a primary anti-FMRP antibody or b-actin for loading control overnight at 48C in 1% milk in PBS-T. Specific secondary horseradish peroxidase (HRP)-conjugated antibodies were used at 1:2,500 dilution (Santa Cruz, Biotechnology, Dallas, TX) and blots were developed with SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific, Waltham, MA) and exposed to X-ray film. 
Data analysis
From each brain, every fourth section was stained for 7G1 immunoreactivity, 2F5 immunoreactivity, and Nissl. For each set of staining, there were a total of 105-115 coronal sections from the spinal cord to the olfactory bulb or 50-60 parasagittal sections from the lateral surface to the midline. To avoid staining variations across slides and sections, sections within the same series were treated the same way and simultaneously whenever possible. For each section, image tiles were captured at 16 bits with a 203 lens and an Axiocam 503 color camera mounted on a Zeiss Imager M2 microscope. While imaging, an autofocus function in the Zeiss Zen software was applied to ensure all image tiles were in focus. The image tiles were then montaged using the titling function of the Zeiss Zen software. This imaging protocol generated a single image of the entire section at a high resolution. All sections were captured and subsequently processed using the same parameters, so that the optical density of the background was within 1% deviation across images. Here the background is referred to a region on the slide without brain tissue present. Image brightness and contrast adjustments were performed using Adobe PhotoShop (Adobe Systems, Mountain View, CA). All drawings were produced in Adobe Illustrator (Adobe Systems).
All subsequent quantitative analyses were based on measurements from 7G1 immunostaining. To reveal FMRP-rich cells throughout the mouse brain, we performed a pixel-based threshold analysis. The tiled image of an entire section was converted to 8 bit in black and white and used to generate a threshold image at the pixel brightness point of 114 using Fiji software (v. 1.50e; National Institutes of Health, Bethesda, MD). This threshold was chosen to reveal high intensities of FMRP staining and was applied to all sections analyzed.
To compare FMRP expression levels between cell groups, we performed an intensity analysis on FMRP immunostaining at the individual cell level in 85 selected neuronal cell groups. For each cell group, all 7G1-labeled coronal sections containing a significant portion of this cell group were identified. The most middle sections through each cell group were used to determine the cells to be measured based on the following criteria: 1) its location can be unambiguously identified within the border of the cell group; 2) this cell has an identifiable cell boundary and a well-defined nucleus; and 3) the cross-sectional cell body area of this cell is To analyze a minimum of 30 cells from each cell group, a single section was used for large cell groups, while multiple sections were used for smaller cell groups. Once a section was included in the analysis for a particular cell group, all cells matching the above criteria were measured.
For each selected cell, the mean optical intensity of FMRP immunostaining within the cell body was measured in the Fiji software (v. 1.50e; NIH). After background subtraction, the optical intensity of each measured cell was normalized to the average optical intensity of all measured cells in the ventral premammillary nucleus (PMv), the cell group with the smallest average optical intensity among all measured cell groups. The background was measured in a region where there was no tissue present. Statistical analyses between cell groups were performed in the Prism software (v. 6; GraphPad Software, La Jolla, CA) using either an unpaired Student's t-test or one-way analysis of variance (ANOVA) followed by Tukey's multiple comparisons test. Only cell groups presented and measured from the same sections were compared statistically to minimize false positives.
To avoid individual bias in selecting cells to be measured and in outlining the border of the cell body, we selected 13 out of 85 cell groups and had them measured independently by three individual experimenters. The three sets of measurements generated demonstrate similar results in comparing FMRP staining intensity between the 13 cell groups, indicating that individual bias, if any, does not affect the main conclusion of the study. All data presented in the Results section resulted from the measurements from one experimenter.
One consideration is to what degree the cellular quantification performed here represents the entire neuronal population in the mouse brain. The goal of the current study was to provide qualitative and quantitative comparisons of FMRP expression levels across the whole brain from brainstem and midbrain to thalamus and cortex. This breadth of objectives limits the depth of the analyses. First, our description and measurements focus on the most prominent cell groups readily identifiable based on FMRP immunostaining. Therefore, neuronal cell groups that are small or without discrete borders from surrounding areas were not taken into (7G1) immunostaining was deposited in the Biolucida Cloud server maintained by MBF Biosciences (Williston, VT). Second, many of the cell groups selected for the analyses have heterogeneous internal organization with multiple subdivisions and/or cell types. We did not attempt to differentiate these subdivisions or cell types unless they are readily identifiable and they differ in their FMRP staining pattern. Third, our cell sampling (n 5 30-60 neurons per cell group) is approximately from the middle of each cell group in coronal sections, rather than random sampling from the entire population of the cell group. Finally, to preferentially represent neuronal vs. glial populations, we analyzed cells with a minimal cross-sectional cell body area of 40 lm 2 . This approach does not take into account neurons of smaller sizes and glial cells of larger sizes. Taken together, our analyses provide a general sampling from these cell groups, with the hope to stimulate more elaborative studies in specific brain areas in conjunction with functional studies.
RESULTS

Characterization of FMRP antibodies
Two monoclonal anti-FMRP antibodies, 7G1 and 2F5, were tested for their specificity of recognizing mouse FMRP in our preparations (Fig. 1) . The antigens are located in the N-terminal and exon 11 for 2F5 and 7G1, respectively, both of which are common for the 12 mouse FMRP isoforms identified by Brackett et al. (2013) . On Western blots, both antibodies detect FMRP bands on wildtype mouse brain samples (WT in Fig.  1A ). These bands are absent on FMR1 knockout mouse brain samples except for a weak low-molecular band for 7G1 detection (KO in Fig. 1A ). The specificity of the two antibodies was further evaluated by immunocytochemistry. Throughout the entire brain of FMR1 knockout mice, no detectable immunostaining was found for 7G1 and 2F5 antibodies (Fig. 1B) except for a strong 7G1 signal in the ependymal and subendymal layers of the lateral ventricle, sometimes called "olfactory ventricle" (Fig. 1C) . Consistently, the olfactory ventricle is labeled in the wildtype mouse brain for 7G1 but not for 2F5 (Fig. 1D,E) . We conclude that this 7G1 staining in the olfactory ventricle is not specific for FMRP. Except for the olfactory ventricle, the distribution pattern of the immunostaining is comparable between 7G1 and 2F5 throughout the wildtype mouse brain, consistent with the assumption that both antibodies recognize all major isoforms of the mouse FMRP. With our staining protocol, 7G1 demonstrates a larger dynamic range of immunostaining intensity than 2F5. In other words, 7G1 illustrates differential patterns of FMRP distribution across brain regions in a more dramatic manner. The subsequent description, illustrations, and quantification are thus based on 7G1 immunostaining.
General distribution pattern of FMRP immunoreactivity
Although FMRP immunoreactivity is presented throughout the entire brain, the low-magnification images nicely demonstrate that the intensity of FMRP staining varies largely across brain regions. Figures 2-4 illustrate FMRP staining on three parasagittal sections as well as Nissl stain on adjacent sections. For the purpose of description, we divide the mouse brain into seven major portions: 1) the brainstem; 2) the midbrain; 3) the cerebellum; 4) the thalamus; 5) the hypothalamus; 6) the cerebral cortex, which contains the isocortex, hippocampus, olfactory bulb, and cortical subplate; and 7) the cerebral nuclei, which contains striatum and pallidum. Consistent with a previous study (Hinds et al., 1993) , the most prominent FMRP staining at low magnification is seen in the olfactory bulb, isocortex, hippocampus, thalamus, and cerebellum. In contrast, the staining level is generally low in the hypothalamus and midbrain. The entire thalamus stands out with high and relatively uniform levels of FMRP immunoreactivity, surrounded by the generally pale staining in the hypothalamus and midbrain. The brainstem, which contains a low density of neuronal cell bodies and a large number of axonal fibers as demonstrated by Nissl stain, is characterized with many distinct FMRP-rich cell groups.
Figures 5-14 illustrate FMRP staining on 12 coronal sections from caudal (the spinal cord) to rostral (the olfactory bulb). Each figure contains the original Table 2 . For naming individual neuronal cell groups, we adopt the nomenclature of the Allen Mouse Brain Atlas (http://atlas.brain-map.org). For identifying the rostral-caudal and the lateral-medial levels of the illustrated images, we compare our sections with the Mouse Brain Atlas (Paxinos and Franklin, 2013) .
To further quantify the differential expression levels of FMRP among individual neuronal cell groups, we measured and compared the intensity of FMRP immunoreactivity in individual cell bodies in 85 selected neuronal cell groups (Fig. 15) . At the cellular level, FMRP is most extensively localized in the cytoplasm of cell bodies. Labeled cell bodies vary greatly in size. It is a reasonable assumption that the majority of small cell bodies in the white matter are glial cells, while large cell bodies in the gray matter are mostly neuronal. In general, FMRP staining intensity is consistently low in the white matter. Our quantification and subsequent description focus on FMRP distribution pattern in the gray matter with respect to individual cell groups listed in the brain atlas. These cell groups are commonly called nuclei or neuronal cell groups, as they are generally identified based on packaging patterns of neuronal cell types. Within individual neuronal cell groups, we did not attempt to differentiate glial from neuronal cells. Our cellular quantification analyses include only labeled cell bodies with a cross-sectional cell body area larger than 40 lm 2 , which excludes a large percentage of glial cells and, thus, preferentially represents neuronal population. 
FMRP staining in the brainstem and spinal cord
Our samples include only the most rostral portion of the spinal cord containing C1-2 segments. In this portion, the spinal cord contains FMRP-rich cells of various sizes throughout the gray matter (Fig. 16A) . Labeled cells were detected in both dorsal and ventral horns, indicating that both sensory and motor neurons contain FMRP. A group of large cells display particularly intense staining in the ventral horn (Fig. 16B, arrows) , intermixing with cells with relatively lighter staining (Fig. 16B,  arrowheads) . The white matter of the spinal cord contains weakly labeled small cells, presumably glial cells (Fig. 16C, arrowheads) .
In the caudal brainstem (Fig. 17) , the inferior olive complex (IO), the magnocellular part of the lateral reticular nucleus (LRNm), the nucleus raphe pallidus and obscurus (RPA and RO), the external cuneate nucleus (ECU), and the dorsal motor nucleus of the vagus nerve (DMX) all stand out prominently, with a remarkably high (Fig. 17A-I) . Darkly labeled cells are also found in the gracile nucleus (GR), the cuneate nucleus (CU), the giganticellular reticular nucleus (GRN), the abducens nucleus (VI), the facial motor nucleus (VII), and the spinal nucleus of the trigeminal (SPV). The SPV contains several subdivisions with a wide span along the rostrocaudal dimension. FMRP-rich cells are detected throughout this complex, mixed with cells with relatively low intensities of FMRP immunoreactivity. Similarly, the reticular nucleus contain both darkly and weakly labeled cells. In contrast, most cells are weakly labeled in the hypoglossal nucleus (XII) and the nucleus of the solitary tract (NTS), which are immediately adjacent to DMX (Fig. 17J,K) . Quantification analysis confirms a significantly higher intensity of FMRP immunoreactivity in DMX than XII at the individual cell level (P < 0.0001; Fig. 15A ).
At more rostral levels, where the vestibulocochlear nerve enters the brainstem (Fig. 18) , auditory nuclei exhibit high levels of FMRP, including the dorsal and ventral portions of the cochlear nucleus (DCO and VCO; Fig. 18A ), the superior olivary complex (SOC; Fig. 18E ), the nucleus of the trapezoid body (NTB; Fig. 18E ), and the nuclei of the lateral lemniscus (NLL; Fig. 18B ). The two portions of the cochlear nucleus, DCO and VCO, exhibit different staining patterns. VCO contains distinct darkly labeled cell bodies throughout the nucleus, while cells in DCO are more closely packed and exhibit a wide range of FMRP staining intensity. The intensity of FMRP immunostaining is significantly higher in VCO than in DCO (P < 0.0001; Fig. 15A) . A differential FMRP staining pattern is also seen between SOC and NTB. The staining intensity of NTB cells appears higher than that of the adjacent SOC nuclei including the lateral superior olive (LSO), the medial superior olive (MSO), and the superior paraolivary nucleus (SPO). This observation is confirmed with quantitative comparison between NTB and LSO (P < 0.05; Fig. 15A ). Similarly, FMRP intensity in the vestibular nuclei is not uniform. The medial portion of the vestibular nucleus (MV) shows lower FMRP staining intensities than the lateral, superior and spinal portions (LAV, SUV, and SPIV; Fig.  18C,D) . These differences are statistically significant (P < 0.01-0.0001; Fig. 15A ). The most rostral portion of the brainstem (Fig. 19) is largely occupied by the pontine reticular nucleus (PRN). PRN is low in FMRP immunostaining in general, although scattered neurons with strong labeling are also found (see Fig. 7 ). The tegmental reticular nucleus (TRN) and the pontine gray (PG) are heavily loaded with FMRP, in high contrast to the surrounding areas in the brainstem and midbrain (Fig. 19A) . The principal sensory nucleus of the trigeminal (PSV) and the motor nucleus of trigeminal (V) also contain a high density of FMRP-rich cells (Fig. 19B) . It is interesting to note a group of intensely stained cells embedded in the motor root of the trigeminal nerve. These cells are smaller and more darkly labeled than the cells in the adjacent motor nucleus of trigeminal (Figs. 15B, 19B ).
FMRP staining in the midbrain
FMRP staining is generally low in the midbrain (Fig.  20) . Nevertheless, a number of cell groups containing substantial FMRP immunoreactivity are detected. First, cells in both the external and central nuclei of the inferior colliculus (ICe and ICc) are darkly labeled, with comparable staining intensities (Fig. 15A, 20A-C) . In contrast, cells in the adjacent periaqueductal gray (PAG) are weakly labeled (Fig. 20D) . Second, the large cells of the midbrain trigeminal nucleus (MEV) show strong staining and are among the darkest cells for FMRP immunostaining in the entire brain (Figs. (15 and  20)D) . Third, the intermediate gray layer of the superior colliculus (SCig) exhibit a uniquely strong staining for FMRP (Fig. 20E,F) , as compared to other SC layers above and below (P < 0.0001; Fig. 15B ). Fourth, most cells in the parabigeminal nucleus (PBG) exhibit distinctly high levels of FMRP immunostaining (Fig. 20G) . FMRP intensity in PBG is significantly higher than that in SCig (P < 0.0001; Fig. 15B ). Finally, darkly labeled cells are detected in the compact part of the substantia nigra (SNc; Fig. 19C ) and the red nucleus (RN; Fig. 2 ).
FMRP staining in the thalamus
The entire thalamus displays high and relatively uniform levels of FMRP immunoreactivity (Fig. 21) . Notably, differential FMRP intensities are detected in two thalamic areas. The first differential pattern is seen in the lateral geniculate complex (LG). The ventral LG division (LGv) and the intergeniculate leaflet (IGL) show significantly lower FMRP staining intensities than the dorsal LG division (LGd; Fig. 21A-C ; P < 0.001-0.0001; Fig. 15D ). The second differential pattern is seen in the epithalamus where the lateral habenula (LH) is stained notably lighter than the medial habenula (MH; Fig. 21D ). However, cellular quantification reveals no significant difference in FMRP intensity of individual cell bodies between MH and LH (P 5 0.10; Fig. 15D ), indicating that the stronger staining in MH is primarily due to a higher cell density in MH rather than higher FMRP intensities of individual cell bodies (Fig. 21E,F) . Nonetheless, FMRP intensity in both MH and LH are significantly lower than that in the ventrally located parafasciular nucleus (PF; P < 0.001; Figs. 15D, 21D ). 
FMRP staining in the hypothalamus
In contrast to the adjacent thalamus, most of the hypothalamus exhibits strikingly lower FMRP intensity (Fig. 22) . A number of cell groups in the mammillary body, however, show strong FMRP immunostaining, including the lateral mammillary nucleus (LM; Fig. 22A ), the ventral part of the tuberomammillary nucleus (TMv; Fig. 22B ), and the medial part of the medial mammillary nucleus (MMm; Fig. 22D ). In contrast, FMRP staining is weak in the adjacent ventral premammillary nucleus (PMv; Fig. 22F ). Additional hypothalamic nuclei containing darkly labeled cells for FMRP are the dorsomedial nucleus of the hypothalamus (DMH, Fig. 22C ), the tuberal nucleus (TU; Fig. 22E ), the parasubthalamic nucleus (PSTN, Fig. 22G ), and the subthalamic nucleus (STN; Fig. 22H ).
FMRP staining in the cerebellum
Purkinje neurons at the interface between the granular and the molecular layers of the cerebellum have been reported as one of the neuronal cell types that are most reactive to FMRP immunocytochemistry (Devys et al., 1993) . Here we show the average staining intensity within the cell bodies of the Purkinje neurons is medium to strong (Figs. 15B, 23A ). Prominent staining is also seen in the granular layer, which consists of small neurons, while in the molecular layer only few cells show strong labeling. Cells in the three cerebellar nuclei, the fastigial nucleus (FN), interposed nucleus (IP), and dentate nucleus (DN) are stained strongly at comparable levels (Figs. 15B, 23B ).
FMRP staining in the cerebral cortex: isocortex
Throughout the entire isocortex, intense FMRP staining is seen in almost all areas and in every layer (Fig.  24 ). Careful examination with high-power images, however, reveals heterogeneous internal patterns of FMRP distribution within specific isocortex areas. For example, in the rostral portion of the primary somatosensory cortex, small granular cells in layer 4 exhibit notably lower FMRP intensities as compared to other layers, while cells in layers 2-3 appear more darkly labeled than other layers (Fig. 24A) . A more dramatic pattern of low FMRP intensities of layer 4 granular cells is seen in the retrosplenial area, in particular its ventral part (RSPv, called the area 29) (Fig. 24B) . In contrast, cells in layer 4 of the visual area exhibit similar levels of staining as compared to other layers of the same area (Fig. 24C) . As another example of heterogeneous FMRP distribution in the isocortex, a unique group of neurons with particularly intense FMRP staining are found in the anterior cingulate area (ACA; Fig. 24D ). These cells span layers 2/3 and 5 but are not usually found in layer 6. These cells are among the most darkly stained cells in the entire brain. At the level of caudal cortex, it is also noted that FMRP staining intensity is generally (Fig. 8) .
We quantified FMRP intensity at the individual neuron level in four isocortical areas using one-way ANOVA followed with Tukey's test for multiple comparisons (Fig.  15C) . The intensities of FMRP immunoreactivity are significantly different between layers within each cortical area (P < 0.0001). Subsequent comparisons further reveal that layer 4 in area 29 of the retrosplenial area has significantly lower intensity in FMRP than any other layers (P < 0.0001). In addition, FMRP intensity in layer 6a is significantly lower than the adjacent layers 5 and 6b (P < 0.01-0.0001). In the primary visual cortex, cells in layers 1 and 6b have significantly higher FMRP intensities than other layers (P < 0.0001). As expected, layer 4 of the primary somatosensory cortex at the level of the major body of the caudoputamen shows significantly lower FMRP intensity than layers 1, 2/3, and 5 (P < 0.0001), but not layers 6a and 6b. Similar to the somatosensory area, the anterior cingulate area (ACA) shows lower FMRP staining in deep layers 5 and 6 than the more superficial layers 1-3. As expected, FMRP intensity of the darkly labeled cells (DN in Fig. 15C ) spanning layers 2-5 is significantly higher than any other layers of this cortical region (P < 0.01-0.0001). The cortical subplate contains the cell groups in the ventral and adjacent medial to the cortical isocortex, including the claustrum (CLA), the endopiriform nucleus (EP), and several amygdalar nuclei. FMRP immunostaining is strong in most of these cell groups except in the posterior amygdalar nucleus (PA) and the anterior portion of the basomedial amygdalar nucleus (BMAa; Fig.  25 ). Cellular quantification confirms that FMRP intensity in PA is significantly lower than the adjacent basolateral amygdalar nucleus (BLA; P < 0.0001; Fig. 15B ) and FMRP intensity in BMAa is significantly lower than the posterior BMA (BMAp; P < 0.0001; Fig. 15B ).
FMRP staining in the cerebral cortex: hippocampus and olfactory bulb
In all regions of the hippocampus, the pyramidal layer of CA1-3 and the granule cell layer of the dentate gyrus exhibit strong FMRP staining (Fig. 26) . In particular in CA1, FMRP immunoreactivity accumulates intensively in the ventral portion of the pyramidal cell bodies, giving rise to a dark line in FMRP staining at the interface of the pyramidal layer and the stratum radiatum layer (Fig. 26A ). This dark line is not seen in other regions of the hippocampus including CA3 and the dentate gyrus (Fig. 26B,C) . FMRP can also be detected in the proximate portion of the dendrites extending from the CA1 pyramidal layer (arrows in Fig.  26A ). In addition, darkly labeled cells were found scattered in other layers of the hippocampus, including the stratum oriens and radiatum layers of CA1-3, as well as the molecular and polymorph layers of the dentate gyrus (Fig. 26A-C) .
All portions of the olfactory area are rich in FMRP immunoreactivity, including the main olfactory bulb (MOB), the accessory olfactory bulb (AOB), the anterior olfactory nucleus (AON), the piriform area (PIR), the cortical amygdalar area (COA), and the nucleus of the lateral olfactory tract (NLOT; Fig. 14C,D) . Within the MOB, the staining intensity of the cell bodies is lower in the glomerular layer than the mitral layer (Figs. 15D, 26D ).
FMRP staining in the cerebral nuclei: striatum and pallidum
The cortical nuclei contain two major groups, the striatum and pallidum. Most cells in the two groups contain FMRP immunoreactivity at low to medium levels. The caudoputamen (CP), the largest striatum cell group, is clearly less stained than the adjacent isocortex and the cell groups in the cortical subplate (Figs. 15B, 25E-G, 27A,B) . Nonetheless, cells are more darkly stained in CP in general than the nucleus accumbens (ACB) and the fundus of striatum. Within the lateral septal complex, the caudodorsal part of the lateral septal nucleus (LSc) exhibits notably higher FMRP intensities than other cell groups of the complex (see Fig. 11 ). Among the striatum-like amygdalar nuclei, the central and medial amygdalar nuclei (CEA and MEA) exhibit low levels of staining, while the intercalated amygdalar nucleus (IA) contains prominent FMRP staining (Figs. 25D-G, 27F ). All layers of the olfactory tubercle (OT) are rich in FMRP immunoreactivity, including the embedded islands of Calleja (Figs. 12-14, 1997C ). In the pallidum, the most prominent FMRP-rich cells are found in the globus pallidus (GP) and the diagonal band nucleus (NDB; Fig. 27D,E) .
DISCUSSION
In this study we provide a systematic map of the cellular distribution of the fragile X mental retardation protein (FMRP) throughout the mammalian brain. We show that the FMRP expression level is highly differential among individual neuronal cell groups in young mature brains. This finding leads to important implications regarding FMRP function in normal brains and may shed light on understanding the pathology of the fragile X syndrome (FXS).
Differential expression of FMRP in young mature brains
There are two current notions regarding the expression pattern of FMRP in the mammalian brain. The first notion is that FMRP expression is high in some brain areas and low in other regions (Abitbol et al., 1993; Devys et al., 1993; Hinds et al., 1993; Khandjian et al., 1995; Verheij et al., 1995) . This "regional distribution" Cell groups in the olfactory bulb, hippocampus, thalamus, and hypothalamus. FMRP intensities were normalized as described in the Materials and Methods.
Higher intensities indicate higher levels of FMRP staining at the individual cell level. For each cell group, 30 neurons were measured and averaged. Measurements for each cortical area were taken at levels comparable to Fig. 24 . Error bars are SD. *P < 0.01. **P < 0.001. ***P < 0.0001. "ns," not significant.
pattern has led to extensive studies of FMRP function in brain regions with high overall FMRP levels, such as the hippocampus and cortex. The second notion considers FMRP expression at the individual cell level and emphasizes that many neuronal types throughout the brain are as intensely stained for FMRP as the neurons in the hippocampus and cortex (Feng et al., 1997; Christie et al., 2009 ). This "universal distribution" concept argues that strong FMRP signals in some brain regions such as the hippocampus may be related to neuron size and density. This notion is supported by accumulating evidence of altered neuronal structure and function throughout the brain following FMRP loss or reduction, including the brainstem (Brown and Kaczmarek, 2011; Rotschafer et al., 2015) and thalamus (Kogan et al., 2004a) . Using systematic mapping of FMRP immunoreactivity in the entire brain and quantitative analyses at the individual cell level, the current study confirms the widespread distribution of FMRP-rich cells throughout the mammalian brain. More important, this study demonstrates a highly differential pattern of FMRP expression with regard to individual neuronal cell groups. In almost all major brain areas from the brainstem and midbrain to the thalamus and forebrain, cell groups high in FMRP expression are found to be located adjacent to cell groups low in FMRP expression. One of the most striking examples is that the FMRP expression level can differ notably between layers of the same cortical areas and between adjacent cortical areas of the same layers. The overall strong FMRP signal seen in the cortex and hippocampus is partially due to relatively higher percentages of neurons (and probably large glial cells) rich in FMRP in these areas than in other brain regions, in addition to the size and density of general neuronal population, as suggested by Feng et al. (1997) .
It is interesting to speculate about the relationship of FMRP expression with other cellular properties of mature neurons. Clearly, the FMRP expression level of a neuron is not simply related to its general function. In the spinal cord and brainstem, both sensory and motor neurons contain high levels of FMRP. Equally important, not all nuclei involved in sensory processing and motor control express high levels of FMRP (see more discussion below). Consistently, sensory neurons in the thalamus express comparable levels of FMRP to most cortical and hippocampal neurons for cognitive and memory processing. In particular, two nuclei located adjacent to each other and involved in similar functional operations can vary dramatically in the level and pattern of FMRP expression. Examples include the dorsal and ventral portions of the cochlear nucleus, the primary targets of auditory nerve from the inner ear (Brown and Ledwith, 1990) , as well as the anterior and posterior portions of the basomedial amygdalar nucleus, which both are a part of the fear response pathway (Rosen, 2004) .
FMRP expression is also not specific to the type of neurotransmitters a neuron releases or to the expression of a number of biomarkers that characterize specialized neuronal cell types. For example, FMRP level is comparably high in principle neurons of the medial nucleus of the trapezoid body that release glycine (Bledsoe et al., 1990) , hippocampal pyramidal neurons that use glutamate as a neurotransmitter (Deng et al., 2013) , and GABAergic Purkinje neurons in the cerebellum (Saito et al., 1974) . Similarly, nearly all neurons in the inferior olive strongly express both FMRP and calbindin (Yu et al., 2014) , while the cerebellar molecular layer contains numerously darkly labeled small granular cells for FMRP, mostly known to be calbindin-negative (Schwaller et al., 2002) . This broad overlap of FMRP expression with neuronal function and other cellular properties, along with the differential pattern of FMRP between individual cell groups, highlight the importance of FMRP signal in a wide range, but highly selected, brain activities. Exploring the underlying mechanisms of this selection is an important avenue for future investigations and is expected to dramatically enhance our understanding of FMRP regulation in the brain.
Implications related to FMRP function and FXS pathology
If a cell is normally rich in FMRP, it suggests an increased susceptibility of cell structure and function to the loss or reduction of this protein, as compared to other cells that do not express the protein or require lower levels of FMRP for healthy function. It is important to note that the distribution pattern of FMRP described here is in young mature brains of 5-6-weekold mice. Although FMRP expression in the brain begins early in development and continues throughout life (Hinds et al., 1993) , the FMRP level appears to be associated with specific developmental events (Tessier and Broadie, 2008; Cook et al., 2011; Gholizadeh et al., 2015) . Special care should be taken when attempting to associate the distribution pattern of FMRP in mature brains to structural, physiological, and behavioral abnormalities found in FXS patients and FMR1 knockout animals.
These abnormalities are accumulated consequences of constitutive FMRP reduction during the entire development as well as the acute influence of insufficient FMRP regulation after maturity. Furthermore, FMRP has been proposed to play distinct functions at specific developmental stages, from regulating neuronal differentiation during early development, mediating dendritic and synaptic pruning later in development, and to controlling activity-dependent neuronal plasticity after maturity (Till, 2010; Telias et al., 2013; Chaudhury et al., 2016) . Characterization of FMRP cellular distribution patterns at critical developmental stages is essential for exploring specific contributions of various FMRP regulatory mechanisms to normal brain function. Below we discuss how FMRP expression levels in mature brains might be associated with physiological and behavioral outcomes in FXS patients and animals, with an emphasis on activity-dependent neuronal plasticity. This discussion is focused on three brain areas of high interest.
Subcortical sensory processing
Sensory information processing has recently received an increasing amount of attention in studying FXS pathology in humans and animal models (Sinclair et al., 2016) . Abnormal sensory processing is common not only to individuals with FXS but also to autism spectrum disorders in general. One novel finding of our report is the identification of a large number of cell groups with strong FMRP expression in the brainstem, midbrain, and thalamus. Many of these cell groups are involved in fundamental sensory information processing, including auditory, visual, and somatosensory, or in motor control. It is important to note that not all sensory and motor neurons at these subcortical levels are normally rich in FMRP. Most auditory and somatosensory nuclei in the brainstem, midbrain, and thalamus strongly express FMRP. Visual nuclei, on the other hand, exhibit a more selected manner of FMRP expression. Consistent with previous observation in primates (Kogan et al., 2004a) , high levels of FMRP are seen in the mouse dorsolateral geniculate nucleus, the major thalamic target of the ascending pathway from the retina. In contrast, FMRP intensity is relatively low in the superficial layers of the superior colliculus, a retinal LGd; B) and LGv (C). D: FMRP staining appears stronger in the medial habenula (MH) than the lateral habenula (LH). E,F: Closer looks of the neurons in the LH (E) and MH (F). Note FMRP intensity at the individual cell level is comparable between these two cell groups, although MH has a higher cell density. Dashed lines outline the approximate location of different cell groups. Scale bars 5 500 lm in A (applies to A,D); 50 lm in F (applies to B,C,E,F).
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The Journal of Comparative Neurology | Research in Systems Neuroscience target in the midbrain (Butler et al., 2011) . Similarly, not all motor neurons are normally rich in FMRP. Striking differences in FMRP level are seen between the adjacent dorsal motor nucleus of the vagus nerve (DMX) and the hypoglossal nucleus (XII), two primary cell groups of cranial nerves. Taken together, FMRP is selectively expressed at high levels in subcortical sensory and motor neurons in mature brains.
If FMRP-rich sensory neurons are significant targets in FXS, one might expect to see that these neurons exhibit structural and/or functional plasticity in response to changes in neuronal activity in normal brains and that such activity-dependent plasticity is compromised when FMRP is absent. Indeed, hearing loss or abnormal hearing induced by tinnitus leads to extensive alternations in cellular properties of auditory neurons throughout the brain (Rubel and Fritzsch, 2002; Parks and Rubel, 2004; Saunders, 2007; Berger and Coomber, 2015; Tong et al., 2015; Ryugo, 2015; Bayat et al., 2016) . In FMR1 knockout mice, auditory brainstem neurons show altered synaptic connectivity and reduced activity-dependent regulation of ion channel expression and conductance (Brown and Kaczmarek, 2011; Rotschafer et al., 2015) . In primates and humans, FMRP expression in the magnocellular layers of the lateral geniculate nucleus (LGN) is stronger than that in the parvocellular layers of LGN (Kogan et al., 2004a) . Consistently, FXS patients show selective visual deficit of the magnocellular, but not parvocellular visual pathway, although the role of neuronal activity in this visual function is not clear. Similarly, in the olfactory bulb, where FMRP is strongly expressed, neuronal dendritic dynamics in response to alterations of sensory experience are reduced in FMR1 knockout mice (Daroles et al., 2015) , including deficits in learned olfactory function (Larson et al., 2008; Sudhakaran et al., 2014; Nitenson et al., 2015) .
Taken together, these studies strongly implicate the importance of FMRP regulation in selected aspects of fundamental sensory information processing in mature brains at the subcortical levels. This implication argues that there are two avenues whereby FXS can influence cortical function, where the sensory perception is thought to be generated. One is the influence of FMRP on the development and maintenance of the cortical neurons themselves. The second is through altered sensory signals they receive due to abnormal functioning and/or abnormal connectivity of sensory neurons in the brainstem, midbrain, and thalamus. Therefore, in addition to studies of cortical neurons, investigations of FMRP function at subcortical levels may be both experimentally advantageous and clinically significant; sensory processing circuits at the subcortical levels are often more thoroughly characterized and may be more conserved across vertebrate species than cortical neural circuits. 
Hypothalamus
The hypothalamus is in general low in FMRP in mature brains with the exception of a number of cell groups of the mammillary body. The mammillary body is closely related to the hippocampus and plays an important role in spatial memory (Vann and Nelson, 2015) . The finding of a high FMRP level in the mammillary body is of particular interest in light of memory and learning deficits in FXS individuals and extensive documentation on reduced neuronal plasticity of hippocampal neurons in FMR1 knockout mice (Mercaldo et al., 2009) . The current study found varied FMRP expression levels among distinct cell groups of the mammillary body, suggesting differential contribution of each cell group to memory deficits in FXS.
Data on neuroendocrine function of the hypothalamus are seemingly disparate. Hypothalamic nuclei are known to control food intake, body temperature, fatigue, sleep, and circadian rhythms (Bakos et al., 2016) . A number of neuroendocrine studies implicated hypothalamic dysfunction in FXS, including abnormal activation of the hypothalamic-pituitary-adrenal axis (Hessl et al., 2004) . In addition, significantly reduced neuronal activity was reported in the hypothalamus of FMR1 knockout mice of 5-week-old mice (Michalon et al., 2013) . These studies may help to explain the abnormal stress responses, sleep abnormalities, and physical growth patterns commonly seen in affected individuals (Bregman et al., 1990; Hessl et al., 2004) . Low FMRP expression in most hypothalamic nuclei at comparable ages appears inconsistent with these behavioral studies. This could also be showing us one of the differences in FMRP expression in mice and human brains. Alternatively, it may suggest the importance of FMRP to hypothalamus during development rather than at relatively more mature stages. Consistent with this idea is the significant increase in the gray matter volume in hypothalamus found in 1-3-year-old but not older (Gothelf et al., 2008) children with FXS based on magnetic resonance imaging studies. It is clear that further research is needed to consolidate these seemingly disparate findings, but it does raise the possibility that FMRP may be differentially expressed at different levels in developing hypothalamic nuclei.
Cortex layer 4
Reduced neuronal plasticity of various cortical cell types is repeatedly reported in FMR1 knockout animals (for example, Li et al., 2002; Gocel et al., 2012; Padmashri et al., 2013; Yang et al., 2014; Koga et al., 2015; Martin et al., 2016; Nagaoka et al., 2016) . FMRP is strongly expressed in almost all layers throughout the neocortex in mature brains. However, the FMRP protein level is not uniform. For example, small granule neurons of layer 4, the primary cortical targets of ascending thalamic inputs, exhibit significantly lower FMRP levels as compared to other layers in area 29 and some somatosensory areas. Interestingly, layer 4 is uniquely highly developed in area 29, with a Figure 27 . High-magnification images of FMRP (7G1) immunostaining in the striatum and pallidum. FMRP staining is stronger in the caudoputamen (CP; A), the islands of Calleja (isl; C), the diagonal band nucleus (NDB; D), and the globus pallidus (GP; E), than in the nucleus accumbens (ACB; B) and the central amygdalar nuclei (CEA; F). Arrows in B indicate two more darkly labeled neurons in ACB. Dashed line in C outlines the boundary of one island of Calleja. Scale bar 5 100 lm.
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The Journal of Comparative Neurology | Research in Systems Neuroscience corresponding reduction of layers 2 and 3 (Brodmann, 1909) . Area 29, a portion of the retrosplenial cortex, is thought to participate in memory, navigation, and other cognitive functions (Vann et al., 2009 ). In the somatosensory area, Till et al. (2012) reported alterations in dendritic and spine morphology of spiny stellate neurons of layer 4. Whether structural changes occur to small granule cells in the same layer is unknown, probably due to the difficulty of studying this cell type (see discussion in Wang et al., 2010) . Layer-specific expression of FMRP is also found in another laminar structure, the superior colliculus. Although the significance and implications of these differential expression patterns in FMRP neurobiology and FXS pathology are unknown, it amplifies the importance of studying FMRP mechanisms with the resolution of individual layers and cell types.
CONCLUSION
The findings presented in this study provide fundamental background information for understanding FMRP function in the mature brain. Additional complementary studies assessing cellular distribution patterns at critical developmental stages will be essential for exploring specific contribution of various FMRP regulatory mechanisms to normal brain function. In addition, our findings emphasize the need and advantages of studying sensory information processing at subcortical levels for understanding FMRP functions in normal and FXS brains.
